BACKGROUND: Encephalitis is an inflammatory condition of the brain associated with long-term neurologic sequelae and even death in children. Although viruses are often implicated, an etiology is not identified in the majority of cases. Metagenomics-based next-generation sequencing (mNGS) is a high-throughput sequencing technique that can enhance the detection of novel or low-frequency pathogens. METHODS: Hospitalized immunocompetent children aged 6 months to 18 years with encephalitis of unidentified etiology were eligible for enrollment. Demographic, historical, and clinical information was obtained, and residual blood and cerebrospinal fluid (CSF) samples were subjected to mNGS. Pathogens were identified by querying the sequence data against the NCBI GenBank database. RESULTS: Twenty children were enrolled prospectively between 2013 and 2017. mNGS of CSF identified 7 nonhuman nucleic acid sequences of significant frequency in 6 patients, including that of Mycoplasma bovis, parvovirus B19, Neisseria meningitidis, and Balamuthia mandrillaris. mNGS also detected Cladophialophora species, tobacco mosaic virus, and human bocavirus, which were presumed to be contaminants or nonpathogenic organisms. One patient was found to have positive serology results for California encephalitis virus, but mNGS did not detect it. Patients for whom mNGS identified a diagnosis had a significantly higher CSF white blood cell count, a higher CSF protein concentration, and a lower CSF glucose level than patients for whom mNGS did not identify a diagnosis. CONCLUSION: We describe here the results of a prospective cohort analysis to evaluate mNGS as a diagnostic tool for children with unexplained encephalitis. Although mNGS detected multiple nonpathogenic organisms, it also identified multiple pathogens successfully and was most useful in patients with a CSF abnormality.
BACKGROUND:Encephalitis is an inflammatory condition of the brain associated with long-term neurologic sequelae and even death in children. Although viruses are often implicated, an etiology is not identified in the majority of cases. Metagenomics-based next-generation sequencing (mNGS) is a high-throughput sequencing technique that can enhance the detection of novel or low-frequency pathogens. METHODS: Hospitalized immunocompetent children aged 6 months to 18 years with encephalitis of unidentified etiology were eligible for enrollment. Demographic, historical, and clinical information was obtained, and residual blood and cerebrospinal fluid (CSF) samples were subjected to mNGS. Pathogens were identified by querying the sequence data against the NCBI GenBank database. RESULTS: Twenty children were enrolled prospectively between 2013 and 2017. mNGS of CSF identified 7 nonhuman nucleic acid sequences of significant frequency in 6 patients, including that of Mycoplasma bovis, parvovirus B19, Neisseria meningitidis, and Balamuthia mandrillaris. mNGS also detected Cladophialophora species, tobacco mosaic virus, and human bocavirus, which were presumed to be contaminants or nonpathogenic organisms. One patient was found to have positive serology results for California encephalitis virus, but mNGS did not detect it. Patients for whom mNGS identified a diagnosis had a significantly higher CSF white blood cell count, a higher CSF protein concentration, and a lower CSF glucose level than patients for whom mNGS did not identify a diagnosis. CONCLUSION: We describe here the results of a prospective cohort analysis to evaluate mNGS as a diagnostic tool for children with unexplained encephalitis. Although mNGS detected multiple nonpathogenic organisms, it also identified multiple pathogens successfully and was most useful in patients with a CSF abnormality.
Authors: Rubén S Rosales; Roberto Puleio; Guido R Loria; Salvatore Catania; Robin A J Nicholas Journal: Res Vet Sci Date: 2017-09-05 Impact factor: 2.534
Authors: Steven L Salzberg; Florian P Breitwieser; Anupama Kumar; Haiping Hao; Peter Burger; Fausto J Rodriguez; Michael Lim; Alfredo Quiñones-Hinojosa; Gary L Gallia; Jeffrey A Tornheim; Michael T Melia; Cynthia L Sears; Carlos A Pardo Journal: Neurol Neuroimmunol Neuroinflamm Date: 2016-06-13
Authors: Briana R Flaherty; Joel Barratt; Meredith Lane; Eldin Talundzic; Richard S Bradbury Journal: Microbiome Date: 2021-01-02 Impact factor: 14.650
Authors: Nanda Ramchandar; Nicole G Coufal; Anna S Warden; Benjamin Briggs; Toni Schwarz; Rita Stinnett; Heng Xie; Robert Schlaberg; Jennifer Foley; Christina Clarke; Bryce Waldeman; Claudia Enriquez; Stephanie Osborne; Antonio Arrieta; Daria Salyakina; Michelin Janvier; Prithvi Sendi; Balagangadhar R Totapally; David Dimmock; Lauge Farnaes Journal: Open Forum Infect Dis Date: 2021-03-06 Impact factor: 3.835
Authors: Anne Piantadosi; Shibani S Mukerji; Simon Ye; Tracey A Cho; Pardis Sabeti; Michael J Leone; Lisa M Freimark; Daniel Park; Gordon Adams; Jacob Lemieux; Sanjat Kanjilal; Isaac H Solomon; Asim A Ahmed; Robert Goldstein; Vijay Ganesh; Bridget Ostrem; Kaelyn C Cummins; Jesse M Thon; Cormac M Kinsella; Eric Rosenberg; Matthew P Frosch; Marcia B Goldberg Journal: mBio Date: 2021-08-31 Impact factor: 7.867